Rachel Vatnsdal
Stock Analyst at JP Morgan
(1.46)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
HSIC Henry Schein | Maintains: Overweight | 80 76 | 66.11 | 14.96% | 4 | Aug 7, 2025 | |
ADPT Adaptive Biotechnolo... | Maintains: Overweight | 10 14 | 12.14 | 15.32% | 5 | Aug 6, 2025 | |
AVTR Avantor | Maintains: Overweight | 17 14 | 12.11 | 15.61% | 1 | Aug 4, 2025 | |
CAI Caris Life Sciences | Initiates Coverage On: Overweight | 31 | 30.21 | 2.62% | 1 | Jul 14, 2025 | |
TXG 10x Genomics | Maintains: Neutral | 12 9 | 12.31 | -26.89% | 4 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 40 33 | 27.63 | 19.44% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 200 190 | 111.93 | 69.75% | 6 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 120 100 | 85.81 | 16.54% | 4 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 20 19 | 20.19 | -5.89% | 4 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 380 390 | 279.45 | 39.56% | 4 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 50 55 | 60.81 | -9.55% | 3 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 50 55 | 54.81 | 0.35% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 165 160 | 114.15 | 40.17% | 6 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 650 670 | 462.25 | 44.94% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 17 20 | 6.21 | 222.06% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1300 1400 | 1257.25 | 11.35% | 2 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 60 90 | 30.8 | 192.21% | 2 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 250 270 | 199.79 | 35.14% | 4 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Nov 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 90 45 | 63.48 | -29.11% | 1 | May 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Nov 10, 2022 |